VoxEU Column Public preferences for prioritising a COVID-19 vaccine Jeroen Luyten Sandy Tubeuf Roselinde Kessels 25 Nov 2020 COVID-19
VoxEU Column Vaccines against COVID-19 are on the horizon; now is the time to manage the transition rationally Flavio Toxvaerd Miltos Makris 24 Nov 2020 COVID-19
VoxEU Column On the production of and equitable access to COVID-19 tests, treatments, and vaccines Pascal Lamy 6 Nov 2020 COVID-19
VoxEU Column Profits vs integrity: Why we may trust registered clinical trials Christian Decker Marco Ottaviani Jérôme Adda 16 Sep 2020 COVID-19 Health Economics
Discussion paper DP10474 Vaccines vs. Preventives Michael Kremer Christopher Snyder 8 Mar 2015 Development Economics Industrial Organization D42 I18 L11 O31
Discussion paper DP6808 On the Optimal Production Capacity for Influenza Vaccine Rikard Forslid Mathias Herzing 25 Apr 2008 Industrial Organization D42 D62 H10 I18 L10
Discussion paper DP4980 Can we Trust Private Firms as Suppliers of Vaccines for the Avian Influenza? Rikard Forslid 23 Mar 2005 Industrial Organization D42 D62 H10 I18 L10